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The following chapter addresses vascular fibroblasts in a healthy, quiescent 
state, as well during vascular inflammation, focusing on atherosclerosis. The 
development of atherosclerosis, an inflammatory disease of medium- and large-
sized arteries, has traditionally been viewed as an “inside-out” mechanism, with 
prominent roles of the innermost layer of the artery, consisting of endothelial cells. 
However, emerging evidence suggests a new paradigm of “outside-in” mechanism, 
including an earlier role for fibroblasts, constituents of the outermost adventitial 
layer of the artery. Phenotypic and functional changes of fibroblasts in adventitia 
may even occur prior to, or alongside endothelial activation. Activated adventitial 
fibroblasts, implicated in atherosclerosis progression, begin to transform into 
myofibroblasts, upregulate production of different proinflammatory cytokines, 
chemokines, growth factors, proteolytic enzymes, extracellular matrix proteins 
and reactive oxygen species, leading to extensive matrix remodeling, chemotaxis 
and recruitment of immune cells. Due to their suitable location for drug delivery 
systems, preventing fibroblast activation, modulating their activity or inducing 
myofibroblast dedifferentiation could represent a promising therapeutic approach 
for atherosclerosis regression.
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1. Introduction
Fibroblasts are mesenchymal cells that are morphologically characterized as 
adherent, flat, elongated (spindle-shaped) cells with leveled, oval nuclei. One of 
their major roles is to produce and integrate structural proteins, such as collagen, 
elastin, and proteoglycans into the extracellular matrix (ECM) of most mesenchymal 
tissues and thus maintain their structural integrity [1].
In healthy arteries, fibroblasts can be found in the adventitia, the outermost 
layer of the vessel wall. Adventitial fibroblasts display numerous subtypes, even 
in a quiescent state, however, very little is known about their exact involvement in 
atherosclerosis development and progression [2]. Most of the attributed functions 
of adventitial fibroblasts have been largely extrapolated from findings describing 
fibroblasts in different tissues and organs, such as the skin. However, fibroblasts 
from different anatomic sites and tissues are functionally and phenotypically 
distinct. For example, cultured fetal and adult human skin fibroblasts derived 
from different anatomical sites expressed distinct transcriptional patterns of 
genes involved in extracellular matrix synthesis, lipid metabolism, and cell signal-
ing pathways regulating proliferation, cell migration and fate determination [3]. 
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The discovered topographic differences of fibroblasts might be connected to the 
positional memory since adult fibroblast maintain key features of the HOX gene 
pattern expression, established during embryogenesis. Indeed, many HOX genes 
that encode a family of evolutionarily conserved transcription factors, are differ-
entially expressed in fibroblasts derived from different anatomical sites, indicating 
that fibroblasts from each topographic site express a unique HOX gene expression 
pattern [3, 4].
Fibroblasts are metabolically active cells that play a central role in, not only 
matrix maintenance and remodeling and regulating ECM, but also in managing 
interstitial fluid volume and pressure, new tissue formation and wound healing. 
They have been found to be associated with many connective tissue pathologies, 
either due to their direct implication in the disease mechanism or due to the resulting 
fibrosis associated with damage in other cell types [5]. Recently, novel mechanisms 
proposed a prominent role of fibroblasts also in the development and progression of 
atherosclerosis. Atherosclerosis is a chronic, fibro-proliferative disease of the arterial 
vessel walls that underlies the development of many cardiovascular diseases (CVDs) 
and affects the structure and function of the involved arteries [6].
Vascular inflammation, leading to atherosclerosis, has been traditionally viewed 
as an “inside-out” response, beginning with the activation of endothelium and an 
inflammatory response that spreads outwards, from the intima towards media and 
adventitia, ultimately forming fibrous plaque and damaging all three vessel wall 
layers [7, 8]. The classical mechanism of atherogenesis has been challenged recently 
with emerging evidence supporting a new hypothesis of an “outside-in” mechanism, 
in which vascular inflammation actually begins in the adventitia and progresses 
inward towards the media and intima [8, 9], suggesting a more prominent role of 
fibroblasts than previously thought.
So, in order to pinpoint, the potential role of fibroblasts during atherosclerosis 
progression, we need to first look at the arterial wall composition and function.
2. Vessel wall structure and fibroblasts
2.1 Arterial vessel wall structure
Characterization of the resident, stromal cell populations and subpopulations 
in a blood vessel is an important step in understanding cellular contribution to 
vascular development and disease. Since atherosclerosis is prevalently a disease of 
large- and medium-sized arteries [10], we will focus here on the description of the 
structure of these vessels and corresponding vascular stromal cell populations.
The walls of large- and medium-sized arteries are a heterogeneous three-layered 
structure consisting of the tunica intima, media and adventitia. Each layer is 
unique in its histologic, biochemical and functional properties and is differentially 
involved in maintaining vascular homeostasis and regulating the vascular response 
to stress or injury [8]. The tunica intima or innermost layer represents a monolayer 
of endothelial cells, which are in direct contact with the blood flow. The intima is 
separated from the tunica media by a basement membrane and an internal elastic 
lamina. The tunica media consists of multiple layers of vascular smooth muscle cells 
(VSMC). The tunica adventitia or the outermost layer is separated from the media 
by an external elastic lamina and represents the most complex layer of the blood 
vessel [11]. The adventitia is composed primarily of fibroblasts in a loose connec-
tive tissue matrix, and it also contains resident immune cells (e.g. dendritic cells, 
macrophages, mast cells), pericytes, small blood vessels with endothelial cells (vasa 
vasorum), several progenitor cells and adrenergic nerve cells (Figure 1) [12].
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For many years, adventitial cells were thought to have a limited physiological 
“static” function serving as structural support to the blood vessel, supplying oxy-
gen and nutrients to the media of large vessels, and sustaining sympathetic inner-
vation of the vessel wall [14]. However, latest in vivo and in vitro studies have shown 
that the adventitia represents a dynamic microenvironment that regulates both 
structural and functional properties of all three arterial layers [15]. The adventitia 
is an important source of cells that migrate towards the intima and media. For 
example, stem and progenitor cells that function and reside in the adventitia can 
transform into medial and intimal cells, such as VSMCs, and endothelial cells 
[16–18]. The adventitia of coronary arteries also contains cholinergic nerve termi-
nals that release acetylcholine, diffusing to the intima layer of endothelium, where 
it induces the release of nitric oxide, causing VSMC relaxation and vasodilatation 
[19]. After stimulation with angiotensin II, adventitial fibroblasts can synthesize 
and release endothelin-1 (ET-1) that is important in mediating VSMC contrac-
tion [20]. The important role of adventitia is further supported by the role of vasa 
vasorum network, serving as a pipeline for inflammatory cell infiltration during 
vascular inflammation. In atherosclerosis, inflammation contributes to increased 
neovascularization and enhanced permeability of the adventitial vasa vasorum, 
allowing more inflammatory cells to enter the atherosclerotic plaque. Indeed, by 
suppressing the neovascularization of vasa vasorum, Moulton et al. [21] observed 
reduction in numbers of macrophages in atherosclerotic plaques and inhibition of 
atherosclerosis progression in experimental mice models [21]. Additionally, adven-
titial resident cells participate in initiation and regulation of vascular development, 
response to injury and tissue repair and thus, importantly contribute to disease 
development, especially intimal hyperplasia. This is mediated by their ability of 
responding to external physiological stress with intensive tissue repair or arterial 
remodeling [9, 16, 22]. Importantly, resident adventitial cells (e.g. fibroblasts) are 
Figure 1. 
Heterogeneous cellular composition of the vascular adventitia. Compared to arterial intima and media, which 
are composed of endothelial and smooth muscle cells, respectively, the arterial adventitia is composed of a 
variety of heterogeneous cell populations, including fibroblasts, immunomodulatory cells (e.g. dendritic cells, 
macrophages), vasa vasorum, pericytes and adrenergic nerves. The figure was adapted from [13] and created 
using Biorender.
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often the first cells in the vascular wall to become activated in response to hormonal 
and inflammatory stimuli, as well as environmental stress, such as hypoxia/isch-
emia and hypertension [8, 15].
2.2 Fibroblasts in healthy arterial vessel walls
Understanding the role of fibroblasts in normal and pathologic conditions 
is often obstructed by the lack of reliable and specific markers. The fibroblast is 
therefore still one of the most difficult cell types to define in vivo, likely due to their 
heterogeneity (multiple subtypes) and plasticity [23].
In a healthy artery, adventitial fibroblasts are found in a non-active, quiescent 
state, and are usually defined by their location in the vessel wall since they can 
be separated from the more generally recognized smooth muscle cell layer by an 
external elastic lamina [24, 25]. All currently used markers to identify fibroblasts, 
including vimentin, platelet derived growth factor receptor α (PDGFRα), fibroblast 
specific protein 1 (FSP1), discoidin-domain receptor, and prolyl-4-hydroxylase, 
are potentially problematic, as they are also expressed in other cell types and are 
not present in all fibroblasts [3, 26, 27]. Therefore, to identify fibroblasts, investiga-
tors have to rely on the lack of markers for other cell lineages (e.g. non-lymphoid, 
non-endothelium, and non-epithelium), along with morphologic, functional, and 
biochemical characteristics [3].
Adventitial fibroblasts show differences in morphology, size, function and 
activity in the healthy, as well as stressed conditions or disease states [15]. For 
example, An et al. [28] found two major fibroblast subpopulations in the adventitia 
of rat thoracic aorta. The two populations were described as epithelioid-like cells 
and spindle-like cells, however only epithelioid-like fibroblasts were sensitive to 
stimulation with angiotensin II, a hormone involved in the development of hyper-
tension and atherosclerosis [28]. Studying fibroblasts from the adventitia of bovine 
pulmonary artery, Das et al. [29] concluded that numerous phenotypically and 
biochemically distinct fibroblast subpopulations can be found and only a selective 
increase in the number of resident fibroblast subpopulations with enhanced growth 
capability was observed under hypoxic conditions [29].
With the development and increasing popularity of single cell RNA sequenc-
ing technology, it might now be possible to find markers, specific to adventitial 
fibroblasts, as well as to characterize in depth, their subpopulations in normal and 
diseased states [30]. Kalluri et al. [31] explored the cellular atlas of healthy mice 
aortas using single cell RNA sequencing. They showed that fibroblasts represent 
approximately 33% of all aortic cells and were defined by higher expression of 
PDGFRα and collagens/collagen-binding proteins (e.g. Col1a1, Col1a2, Dcn, Lum) 
whereas the expression of VSMC-associated contractile proteins (e.g. Myh11, 
Cnn1) was reduced. These fibroblasts clustered into two subpopulations and are 
probably derived from the adventitia, however their exact location needs to be 
confirmed by immunohistochemistry or in-situ hybridization [31]. Another study 
using the high resolution single cell analysis approach, was performed by Gu  
et al. [32] in aortic adventitial cells from wild type and apolipoprotein E-deficient 
(ApoE−/−) mice. They determined four heterogeneous mesenchymal popula-
tions with differential gene expression suggesting potential functions in ECM 
organization, immune regulation and bone formation. Furthermore, interaction 
of resident, mesenchymal cells with immune cells was enhanced in the adventitia 
of ApoE−/− mice. These data revealed a heterogeneous cellular landscape of the 
adventitia and confirmed fibroblast variability present already in the healthy, 
quiescent state [32].
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3. Adventitial fibroblasts in vascular pathology
3.1 Contribution of adventitial fibroblasts to vascular pathology
In response to injury or environmental stress, adventitial fibroblasts can become 
activated, displaying altered phenotypic and functional properties. Activated 
fibroblasts intensely proliferate and increase production and deposition of ECM 
proteins, as well as proinflammatory cytokines, chemokines, adhesion molecules, 
matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs (TIMPs), and 
growth factors, such as vascular endothelial growth factor (VEGF) [13, 33]. These 
molecules directly affect the phenotype of other resident cells in the vessel wall, such 
as VSMC and endothelial cells, promote neointima formation, regulate vasa vasorum 
expansion and affect the recruitment of infiltrating immune cells [8, 24]. Despite an 
excessive proliferation of activated fibroblasts, no hyperplasia of adventitia is usually 
observed in vascular pathologies. It is likely that many different mediators can also 
activate replication repressor signals in fibroblasts to limit or control replication. For 
instance, protein tyrosine phosphatases that regulate growth factor signaling in vas-
cular remodeling, are upregulated in adventitial fibroblasts in response to vascular 
injury presumably to mitigate proliferative responses [34]. It was also demonstrated 
that adventitial fibroblasts under hypoxic conditions activate protein kinase C-zeta 
and MAPK phosphatase-1 that repress proliferative signals and limit the prolifera-
tion of fibroblasts [35, 36].
Vascular fibroblasts may also produce large amounts of reactive oxygen species 
(ROS) that seem to regulate their proliferation and ECM deposition [37, 38]. 
Activated fibroblasts increasingly interact with other cell types in the arterial 
wall, such as endothelial cells and VSMC and regulate their functions, as well as 
recruit immune cells into the vessel wall [39]. After their activation, some fibro-
blasts differentiate into myofibroblasts that contain bundles of stress fibers and 
can be identified by expression of contractile proteins, such as α-smooth muscle 
actin (αSMA). Multiple stimuli in the microenvironment, such as mechanical 
stress, growth factors (e.g. TGF-β), proinflammatory cytokines (e,g, IL-1β, IL-6, 
TNF-α), adhesion molecules, and ECM molecules can cause differentiation of 
a fibroblast towards the myofibroblast phenotype. Myofibroblasts contribute 
to extensive remodeling, intimal hyperplasia, and luminal stenosis due to their 
invasion and migration into the intima and increased production and secretion of 
ECM proteins [40–43].
The recognition that fibroblasts are not only able to generate, but also to sustain 
inflammatory responses, provides insight into why vascular inflammatory responses, 
in certain situations, fail to resolve. It is suggested that chronic inflammation 
occurs due to dysregulated fibroblast activity in which they fail to switch off their 
inflammatory programme, leading to the inappropriate survival and retention of 
leukocytes within inflamed tissue [44]. It is also clear that the activated adventitial 
fibroblasts play an important role in regulating vasa vasorum growth, which can 
contribute to ongoing vascular remodeling by acting as a conduit for delivery of 
inflammatory and progenitor cells [45].
Recent studies shed light on the implication of adventitial fibroblasts in dif-
ferent vascular pathologies, characterized by arterial remodeling and neointimal 
formation [43]. One of the most persistent findings in experimental in vitro and 
in vivo models is intensive adventitial remodeling, found very early in response to 
vascular injury or stress [46–48]. Adventitial remodeling in the vasculature has 
been characterized by increased proliferation of fibroblasts, which appear to be the 
first cells in the vessel wall that respond to different stimuli by their activation [49]. 
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Direct evidence of fibroblast migration into the intima was provided in a study, 
performed by Li et al. [50], in which primary syngeneic adventitial fibroblasts were 
transduced with β-galactosidase (LacZ) and introduced into the adventitia of rat 
carotid arteries immediately after baloon injury. MRNA expression of LacZ and in 
situ enzymatic activity of β-galactosidase were detected in the media and the neo-
intima, 7 days after injury. On the contrary, in the arteries that were not injured, 
the expression of LacZ and enzymatic activity of β-galactosidase were restricted to 
the adventitia [50]. Similar findings were later reported by Han et al. [51] showing 
that adventitial fibroblasts migrated to the media and intima on seventh day after 
balloon injury in the rat carotid artery. The results were obtained by direct labeling 
of adventitial fibroblasts using in vivo gene transfer technique, as well as transmis-
sion electron microscopy [51]. Furthermore, Dutzmann et al. [52] discovered that 
early activation of adventitial fibroblasts after wire-induced injury in C57BL/6 
mice stimulated their proliferation and release of proinflammatory cytokines and 
growth factors, and the subsequent proliferation of VSMC, resulting in neointima 
formation [52].
Pulmonary artery hypertension (PAH) is one of the vascular pathologies, 
characterized by extensive arterial remodeling and neointima formation, in which 
fibroblasts were shown to play an important role [53]. For example, in the neonatal 
bovine hypoxic PAH model, adventitial fibroblasts were found to undergo the 
earliest and most significant increases in proliferation, among all the vascular wall 
cell types [54]. Fibroblasts derived from experimental hypoxia-induced PAH and 
patients with PAH, display a hyperproliferative, apoptosis-resistant, and proinflam-
matory phenotype, defined by increased production of IL-6, IL-1β, CCL2/MCP1, 
CCL12/SDF1, VCAM1 and osteopontin [13, 55]. Moreover, when naïve bone mar-
row derived macrophages were exposed in vitro to conditioned medium generated 
by adventitial fibroblasts from human PAH patients and hypoxia induced PAH ani-
mals, they increased the transcription of several markers of activation (e.g. Cd163, 
Cd206, Il4ra and Socs3) [56]. These findings suggest that activated adventitial 
fibroblasts in PAH secrete various soluble factors required for macrophage activa-
tion and polarization leading to the propagation of inflammation from adventitia 
towards media and intima, supporting the “outside-in” hypothesis [53].
3.2  The role of fibroblasts in atherosclerosis and potential fibroblast-targeted 
therapy
Several findings suggest a role of fibroblasts in all stages of atherosclerosis, 
from initial phase to fibrous cap and plaque formation. It is becoming evident 
that adventitial cells, including adventitial fibroblasts are one of the first cells to 
respond to injury and become activated in the initial stage of atherosclerosis, even 
before the formation of atherosclerotic lesions, supporting the new “outside-in” 
hypothesis [46, 48].
Studies have shown that in various presentations of CVDs, the adventitia 
becomes heavily populated with multiple immune cell types, including monocytes, 
macrophages and T-cells, while adventitial fibroblasts proliferate increasingly and 
differentiate into myofibroblasts [33, 57–59]. Furthermore, several studies reported on 
increased vasa vasorum neovascularization in early atherosclerosis prior to the devel-
opment of endothelial dysfunction [60, 61]. Neovascularization may act as a pipeline, 
allowing the entry of immune cells into the site of injury, as the density of vasa 
vasorum is highly correlated with the extent of inflammatory infiltrates in ApoE−/− 
mice [21]. These studies indicate that increased neovascularization of vasa vasorum 
in adventitia, that promotes inflammatory response and plaque angiogenesis, can 
occur before the endothelial activation and dysfunction in the intima [8]. Adventitial 
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fibroblasts can regulate the growth and neovascularization of vasa vasorum through 
the release of soluble angiogenic growth factors, such as VEGF, TGF-β and platelet-
derived growth factor (PDGF). Furthermore, with the release of chemokines, such as 
monocyte chemoattractant protein (MCP1), fibroblasts facilitate infiltration of circu-
lating leukocytes, further increasing the growth of the vasa vasorum and perpetuating 
the inflammatory response [37].
Xu et al. [62] investigated the role of adventitial fibroblasts in atherosclerotic 
lesion formation by comparing the characteristics of adventitial fibroblasts from 
ApoE−/− and wild type mice. They found αSMA expressing adventitial fibroblast in 
ApoE−/− mice, but not in wild type mice. The gene expression of collagen I and col-
lagen III was upregulated in adventitial fibroblasts from ApoE−/− mice, compared 
to the wild type mice. Furthermore, adventitial fibroblasts from ApoE−/− mice syn-
thesized more TGF-β, MCP1, and PDGFβ and exhibited proliferatory and migra-
tory properties [62]. MCP1 is important in regulation of migration and infiltration 
of monocytes into the vessel wall, which differentiate into macrophages, form 
foam cells and importantly contribute to fatty streak formation [63]. The effects of 
adventitial fibroblasts are also ascribed to ROS produced by adventitial fibroblast 
NADPH oxidases that play important roles in neointimal formation and growth 
in vascular pathologies, including atherosclerosis [37]. Xu et al. [64] studied ROS 
production and expression of NADPH oxidase subunit p47phox in the hyperlipid 
diet-induced atherosclerosis in the ApoE−/− mouse model. The activated fibroblasts 
from aortas of ApoE−/− mice displayed upregulated NADPH oxidase activity, 
augmented ROS production, and increased p47phox levels, compared with wild-
type mice. ROS production was also associated with the increased proliferation and 
migration of adventitial fibroblasts. In addition, silencing of p47phox decreased 
the proliferation and migration of fibroblasts from ApoE−/− mice [64]. Fibroblasts, 
in response to ROS proliferate and release a number of growth factors and other 
mediators that influence vascular function, including ET1, PDGF, endothelial 
growth factor (EGF), fibroblast growth factor2 (FGF2), prostaglandin H2 (PGH2), 
and cyclophilins [65, 66]. In addition, ROS can also stimulate phenotypic switch of 
VSMC from the contractile to the proliferative and migratory one, suggesting that 
fibroblasts can indirectly influence other cell types inside the vessel wall [38].
In the initial phase of fibrosis, injured arteries start with tissue remodeling, 
and the formation of initial fibrous plaque actually represents a protective pro-
cess; however, as in all chronic inflammatory conditions, fibrotic components in 
the plaque produce surplus levels of cytokines and proteolytic enzymes, causing 
excessive remodeling and tissue damage [59]. In advanced stages of atherosclerosis, 
fibrosis plays a central role and fibroblasts are the major cell population involved 
in remodeling of ECM in the fibrous plaque [59]. The most important functions of 
fibroblasts in progressed atherosclerosis include regulation of the inflammatory 
response, ECM protein production, and maintenance of the structural integrity 
of the plaque as well as regulated balance of MMP production, to enable beneficial 
tissue remodeling, alongside preventing plaque rupture, for instance [59, 67]. 
The potential role of fibroblasts in the development of atherosclerosis is shown in 
Figure 2.
Regulation of fibroblasts activities might be beneficial in controlling or revers-
ing the progression of atherosclerosis, hence, the adventitial fibroblast may be an 
attractive target for therapeutic intervention. Furthermore, the location of the 
adventitia as the outermost arterial layer makes it suitable for drug delivery and 
gene therapy [24]. It has already been shown that local adventitial drug delivery 
into coronary arteries results in better efficiency compared to luminal or intimal 
delivery methods [71]. Low efficiency of gene transfer to cells in adventitia by 
intraluminal administration has been reported and efficient transfection of these 
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cells is achieved only when endothelium is denuded or damaged. In atherosclerotic 
arteries, intimal hyperplasia might present an additional barrier for intraluminal 
delivery. To overcome these problems, delivery from the adventitial side might 
be considered. On the other hand, numerous attempts to transfect or deliver the 
therapeutic agents to the media from the adventitial side of large blood vessels have 
failed because of the impenetrable nature of the external elastic lamina, separating 
adventitia from the media layer. This barrier hence allows for selective adventitial 
delivery and specific targeting of cells residing in adventitia [72].
Perivascular delivery of an adenoviral vector expressing a NADPH oxidase 
inhibitor in the rat carotid artery adventitia significantly reduced neointimal forma-
tion after balloon angioplasty. This specific vector targeted adventitial fibroblasts, 
and it did not affect VSMC in the media [73]. Targeting proteins, expressed by 
activated fibroblasts could attenuate vascular inflammatory responses and ame-
liorate vascular disease, including atherosclerosis. Recently, it was discovered that 
inhibition of expression or activity of fibroblast activation protein (FAP), that is 
expressed in activated but not in quiescent fibroblasts and was found to be associ-
ated with atherosclerotic plaques, can attenuate progression of atherosclerosis by 
increasing plaque stability in experimental mice models of atherosclerosis [74]. 
Figure 2. 
The potential role of fibroblasts during atherosclerosis progression. Emerging evidence suggests that adventitial 
fibroblasts are activated in the initial stage of atherosclerosis, supporting the new “outside-in” hypothesis, 
which proposes that vascular inflammation begins in the adventitia and progresses inward towards the media 
and intima. In contrast, the original “inside-out” hypothesis of atherosclerosis proposes that the inflammatory 
response spreads from the intima outward towards adventitia with a more prominent role of endothelial 
and smooth muscle cells. The figure was adapted from [68–70] and created using Biorender. Legend: ECM, 
extracellular matrix; LDL, low density lipoprotein; ROS, reactive oxygen species; VSMC, vascular smooth 
muscle cells.
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Reports on animal models of cardiomyopathy have indicated that reversibility 
of fibrosis was possible, with losartan (a selective angiotensin II type 1 receptor 
antagonist), which suppressed TGF-β expression [75, 76]. However, angiotensin II 
type 1 receptor is expressed also on VSMC and TGF-β can be produced by multiple 
cell types, in addition to fibroblasts.
A substantial number of adventitial fibroblasts can differentiate into myofi-
broblasts during initial stages of atherosclerosis, upon the influence of proinflam-
matory cytokines, chemokines adhesion molecules, growth factors and ECM 
proteins [33, 77]. For example, TGF-β induces the transition of a fibroblast into 
the myofibroblast by stimulating αSMA expression and collagen production 
[41, 42]. These highly proliferative αSMA-positive cells were found to be widely 
distributed in atherosclerotic plaques [24]. However, myofibroblasts in the athero-
sclerotic plaques can derive from multiple other sources, including VSMC [39], the 
endothelial to mesenchymal transition [78], as well as resident macrophages [79] 
(Figure 3). Myofibroblasts can contribute to changes in the function and struc-
ture of the vessel wall that occur during atherosclerosis (i.e arterial remodeling) 
due to their contractile properties and enhanced ECM protein production [80]. 
Myofibroblasts migrate from the adventitia to the media and intima and contribute 
to intimal hyperplasia [81, 82].
Figure 3. 
Various cells from the arterial wall can differentiate into myofibroblasts in atherosclerosis. Macrophages, 
resident fibroblasts, smooth muscle cells and endothelial cells can differentiate into myofibroblasts, depending 
on tissue microenvironment and inflammatory mediators. Myofibroblasts are characterized by increased 
expression of α-smooth muscle actin and synthesize and release large amounts of ECM proteins, growth factors, 
proinflammatory cytokines, proteolytic enzymes and their inhibitors, as well as reactive oxygen species. They 
are responsible for extensive ECM remodeling, increased chemotaxis and recruitment of immune cells and 
provide signals for further myofibroblast differentiation. The figure was adapted from [41] and created using 
Biorender. Legend: αSMA: α-smooth muscle actin; ECM: extracellular matrix; EMT, endothelial mesenchymal 
transition FGF: fibroblast growth factor; IL: interleukin; NOS: nitric oxide synthase; MMPs: matrix 
metalloproteases; ROS: reactive oxygen species; TGF-β: transforming growth factor-β; TIMPs: tissue inhibitors 
of MMPs; VEGF: vascular endothelial growth factor.
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Although myofibroblasts were previously considered to be terminally differenti-
ated cells, their capacity for dedifferentiation, defined as the loss of αSMA, is now 
well recognized and necessary to resolve idiopathic pulmonary fibrosis [83]. Several 
factors, such as prostaglandin E2 (PGE2), nuclear factor erythroid 2-related factor2 
(Nrf2) and FGFs have shown the ability to dedifferentiate established lung and 
corneal myofibroblasts and might be promising therapeutic targets also for adven-
titial myofibroblasts in atherosclerosis [84]. For example, treatment with PGE2 
was shown to inhibit proliferation and collagen I expression in fibroblasts extracted 
from histologically normal lung tissue [85]. In TGF-β or ET-1-activated lung myo-
fibroblasts, treatment with PGE2 induced a dose-dependent decrease in αSMA and 
collagen I expression that was associated with inhibition of focal adhesion kinase 
signaling [86]. Sulforaphane, a Nrf2 activator, induced myofibroblast dedifferentia-
tion in cultured lung fibroblasts from patients with idiopathic pulmonary fibrosis, 
as well as inhibited TGF-β-mediated profibrotic effects [87]. Corneal myofibro-
blasts that were grown in the presence of FGF1 or FGF2 and heparin reduced 
expression of αSMA, TGF-β receptors, and cadherins, thus promoting the quiescent 
fibroblast phenotype [88]. FGF21 has been shown to induce angiotensin-converting 
enzyme 2 (ACE2), and thus inhibit vascular remodeling, hypertension and fibrosis, 
and when stimulating with adiponectin, FGF21 may inhibit aortic inflammation in 
atherosclerosis, as well as decrease cardiac dysfunction in myocardial infarction, 
attenuate smooth muscle cell proliferation and migration and lower macrophage 
oxidizes low-density lipoprotein uptake [89]. In addition, Fgf21 knock-out mice 
have been reported to show impaired lipid metabolism [90]. So, FGF21 has shown 
promise, as a potential therapeutic for atherosclerosis, but would need further 
investigation in regard to its effects on leukocytes and activities of its receptors.
3.3 The origin of fibroblasts in atherosclerosis
Fibroblast heterogeneity in quiescent and diseased state might be a result of 
their various origins, as well as plasticity, since they can transform into different 
cell types, subsequently to their adaptation to stress or injury. Evidence suggests 
that fibroblasts involved in atherosclerosis may originate from different adventitial 
mesenchymal stem/progenitor cells, however, recent studies revealed they can also 
originate from VSMC or endothelial cells [30].
Several distinct progenitor/stem cell populations with the capacity to differenti-
ate into endothelial cells, VSMC, fibroblasts, and macrophages reside in a special-
ized niche in the adventitia at the media-adventitia border [91]. A population of 
vascular progenitor cells in the aortic adventitia of ApoE−/− mice expressing the 
stem cell markers Sca1 and CD34 was described that might differentiate to vascular 
fibroblasts [92]. However, the exact identity of adventitial progenitor/stem cells is 
still controversial, since fibroblast also have the ability to acquire stem cell properties 
by upregulating Sca1 [93–95]. Moreover, mesenchymal stem cells and fibroblasts 
are similar in terms of morphology and share the expression of a number of surface 
markers, such as CD90, CD73, CD105, vimentin and FSP1. Some researchers there-
fore suggest that these adventitial stem cells positive for Sca1 are actually fibroblasts 
[30, 93]. For example, Tang et al. [96] showed that 40% of Sca1-positive adventitial 
stem cells also express PDGFRα, found to be expressed on the surface of fibroblasts 
[96]. Using single cell RNA sequencing, Gu et al. [32] identified four mesenchymal 
clusters in the aortas of ApoE−/−, as well as wild type mice, but did not annotate 
them as stem or progenitor cells. However, one of the clusters displayed high expres-
sion of Sca1 indicating stem cell properties [32]. The separation between adventitial 
fibroblasts and progenitor/stem cells seem to be much smaller than previously 
thought and cell transition of stem cells into fibroblasts or vice versa appears to be 
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common in atherosclerosis [30]. It would be interesting to further investigate how 
this transdifferentiation would affect the pathological process of atherosclerosis and 
whether it could be targeted to reverse atherosclerosis progression.
The evidence that fibroblasts might originate from VSMC came from Wirka 
et al. in 2019 [97]. They reported that VSMC can transform into fibroblast-like 
cells (termed “fibromyocytes”), found in the arteries of ApoE−/− mice, as well as 
atherosclerotic human coronary arteries. Fibromyocytes expressed lower levels of 
VSMC differentiation markers and increased expression of genes, associated with 
fibroblast cluster, such as lumican, decorin and biglycan. However, fibromyocytes 
were transcriptionally different from the fibroblasts indicating that either they will 
further dedifferentiate into fibroblasts or they might represent another distinct 
population of fibroblasts [97]. Furthermore, it is currently still unclear, whether 
fibroblasts might also transform into VSMC.
Endothelial cells can serve as a possible source of atherosclerotic fibroblasts 
since they can undergo endothelial-mesenchymal transition, promoting atheroscle-
rosis progression [98]. This was elegantly shown in 2016 by Evrard et al. [78] using 
a tamoxifen-inducible endothelial lineage tracking system in ApoE−/− mice. After 
8 weeks of high fat diet, the mouse atherosclerotic plaques consisted of one third 
endothelial-derived cells positive for FAP and a range of other fibroblast markers. 
These cells further expanded in number in advanced atherosclerotic plaques. In 
vitro modeling confirmed that endothelial-mesenchymal transition is driven by 
TGF-β signaling, oxidative stress and hypoxia that are all characteristic for athero-
sclerosis. Furthermore, the extent of this transition correlated with an unstable 
plaque phenotype in humans, driven by altered collagen and MMP production that 
might be associated with clinical events [78].
Whether functional differences between fibroblasts, originating from different 
sources exist and what is their exact contribution to development and/or progression 
of atherosclerosis, still remain two important and open questions.
4. Conclusions
Recently, the well-established “inside-out” hypothesis of atherosclerotic devel-
opment and progression has been revitalized to involve an “outside-in” component, 
including an earlier role for fibroblasts in the tunica adventitia layer. It is now 
thought that early “outside-in” events, with more prominent roles of fibroblasts in 
adventitia may even occur prior to, or alongside endothelial activation. Adventitial 
fibroblasts involved in atherosclerosis comprise a very heterogeneous population, 
due to their differential origins (mesenchymal stem/progenitor cells, smooth 
muscle cells, endothelial cells, macrophages) and an extensive repertoire of possible 
cell transitions into αSMA+ myofibroblasts, or even back to stem cells. It is thought 
that when resident fibroblasts begin to transform into αSMA+ myofibroblasts, 
this allows for intense release of VEGF, TGF-β, collagens, IL-1, IL-6, MMPs, ROS 
and angiotensin II, among other factors, that could lead to perpetual autocrine 
differentiation and inflammatory, proliferative states, responsible for ECM 
remodeling, chemotaxis and recruitment of immune cells. Their heterogeneity 
and consequently, a general lack of specific markers, both contribute to difficulties 
in studying their exact phenotypes and functions in atherosclerosis. The recent 
development and accessibility of single cell RNA sequencing technology provides 
new opportunities to find answers to the remaining questions in an unbiased 
manner. Furthermore, modulating fibroblast activity, preventing their activation or 
inducing myofibroblast dedifferentiation in atherosclerotic arteries could represent 
a promising therapeutic approach for atherosclerosis regression. The plasticity of 
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the atherosclerotic plaque may reform and dynamically remodel many times, before 
either rupturing or, on the other hand, stabilizing with a plaque cap or even regress-
ing, depending on, among many factors, also molecules in the microenvironment 
(micro-exoproteome) and presence of certain cellular profiles that may help lean 
the process either way.
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